DMD Celsis microsomes mean better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
QUICK SEARCH:   [advanced]


     

Drug Metabolism and Disposition Fast Forward
First published on September 30, 2005; DOI: 10.1124/dmd.105.004929

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.105.004929v1
34/1/51    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rufer, C. E
Right arrow Articles by Kulling, S. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rufer, C. E
Right arrow Articles by Kulling, S. E


Received for publication April 5, 2005.
Revised September 28, 2005.
Accepted for publication September 28, 2005.

STRUCTURAL ELUCIDATION OF HYDROXYLATED METABOLITES OF THE ISOFLAVAN EQUOL BY GC/MS AND HPLC/MS

Corinna E Rufer 1, Hansruedi Glatt 2, Sabine E Kulling 3*

1 Federal Research Centre for Nutrition and Food 2 German Institute of Human Nutrition 3 University of Potsdam

* Address correspondence to: E-mail: skulling{at}gmx.de

Abstract

Equol has - as other isoflavonoids - recently gained considerable interest due to its possible health effects. However, detailed studies on the metabolism of equol are scarce. Therefore, we investigated the phase I metabolism of equol using liver microsomes from Aroclor-treated male Wistar rats as well as from a male human. The identification of the metabolites formed was elucidated using high performance liquid chromatography (HPLC) with diode array detection, HPLC/atmospheric pressure ionization electrospray mass spectrometry, gas chromatography-mass spectrometry as well as reference compounds. (+/-)-Equol was converted to eleven metabolites by the liver microsomes from Aroclor pretreated rats comprising three aromatic monohydroxylated and four aliphatic monohydroxylated as well as four dihydroxylated products. The main metabolite was identified as 3'-hydroxy-equol. Using human liver microsomes, equol was converted to six metabolites with 3'-hydroxy- and 6-hydroxy-equol as main products. Furthermore the aliphatic hydroxylated metabolite 4-hydroxy-equol, which was recently detected in human urine after soy consumption, was formed. On the basis of these findings it is suggested that phase I metabolism of equol is part of a complex biotransformation of the soy isoflavone daidzein in humans in vivo.


Key words: cytochrome P450 catalyzed oxidations, GC/MS, HPLC, human CYP enzymes, liver microsomes, metabolite identification


This article has been cited by other articles:


Home page
 Appl. Environ. Microbiol.Home page
A. Matthies, T. Clavel, M. Gutschow, W. Engst, D. Haller, M. Blaut, and A. Braune
Conversion of Daidzein and Genistein by an Anaerobic Bacterium Newly Isolated from the Mouse Intestine
Appl. Envir. Microbiol., August 1, 2008; 74(15): 4847 - 4852.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.